Study S000531

Contribution of a GLP-1 Agonist to Appetite Regulation, Metabolism and Body Composition in Subjects With Prader-Willi Syndrome.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00551343
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: COMPLETED
Enrollment: 20
Start: 2007-10
Primary completion: 2008-09
Lead sponsor: Garvan Institute of Medical Research
Conditions: Prader-Willi Syndrome
Interventions: DRUG:Exenatide
Results posted: FALSE
Secondary identifiers: OTHER:X07-0178

Registered primary outcomes

satiety hormones [1 day]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.